Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Arcus Biosciences, Inc. (RCUS) had Receiveable Turnover of 3.08 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$117.00M |
|
$-307.00M |
|
-- |
|
$117.00M |
|
$457.00M |
|
$-340.00M |
|
$39.00M |
|
$-301.00M |
|
$-301.00M |
|
$-307.00M |
|
$-307.00M |
|
$-307.00M |
|
$-307.00M |
|
$-340.00M |
|
$-351.00M |
|
74.00M |
|
74.00M |
|
$-4.15 |
|
$-4.15 |
|
| Balance Sheet Financials | |
$831.00M |
|
$51.00M |
|
$264.00M |
|
$1.09B |
|
$184.00M |
|
-- |
|
$449.00M |
|
$633.00M |
|
$462.00M |
|
$462.00M |
|
$462.00M |
|
75.50M |
|
| Cash Flow Statement Financials | |
$-306.00M |
|
$194.00M |
|
$33.00M |
|
$209.00M |
|
$130.00M |
|
$-79.00M |
|
$73.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-290.60% |
|
-290.60% |
|
-300.00% |
|
-257.26% |
|
-262.39% |
|
$-330.00M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
|
Receiveable Turnover |
3.08 |
118.55 |
|
-66.45% |
|
-66.45% |
|
-28.04% |
|
-66.45% |
|
$6.12 |
|
$-4.46 |
|
$-4.14 |
|